LAS VEGAS—Urine drug testing (UDT) can be an important tool in risk evaluation and mitigation strategies (REMS) when used in a patient-centered fashion and it is done “for the patient” rather than “to ...

SAN DIEGO — Omitting 24-hour urine testing from multiple myeloma response assessments does not compromise accurate tracking of patients' responses to treatment, a new analysis indicates. Overall, ...